Results 251 to 260 of about 10,125,713 (289)
Some of the next articles are maybe not open access.
Spravočnik vrača obŝej praktiki (Journal of Family Medicine), 2023
Steatohepatitis is a common non-infectious inflammatory disease of the liver, ranking 3rd or 4th in the structure of chronic progressive lesions of the organ. The prevalence of non-alcoholic forms of the disease in the population reaches 11–25 %. In obese patients, the pathology occurs 7 times more often than in those with normal weight.
Seung Hyun Lee, Tu Vinh Luong
openaire +2 more sources
Steatohepatitis is a common non-infectious inflammatory disease of the liver, ranking 3rd or 4th in the structure of chronic progressive lesions of the organ. The prevalence of non-alcoholic forms of the disease in the population reaches 11–25 %. In obese patients, the pathology occurs 7 times more often than in those with normal weight.
Seung Hyun Lee, Tu Vinh Luong
openaire +2 more sources
Non-alcoholic steatohepatitis (NASH)
Current Treatment Options in Gastroenterology, 1999Non-alcoholic steatohepatitis (NASH) is an increasingly common cause of persistently abnormal liver tests. Establishing a diagnosis of NASH requires the secure exclusion of alcohol abuse and hepatitis C as an alternate cause of liver injury. The gold standard of diagnosis is liver biopsy.
, Sorrell, , Mukherjee
openaire +2 more sources
Metformin in non-alcoholic steatohepatitis
The Lancet, 2001There is no established treatment for steatohepatitis in patients who are not alcoholics. This disease is a potentially progressive liver disease associated with hepatic insulin resistance. Only a weight-reducing diet in overweight patients has proved effective.
G, Marchesini +5 more
openaire +2 more sources
Mechanisms of non-alcoholic steatohepatitis
Alcohol, 2004In 1980, the term non-alcoholic steatohepatitis was coined to describe a new syndrome occurring in patients who usually were obese (often diabetic) females who had a liver biopsy picture consistent with alcoholic hepatitis, but who denied alcohol use. The causes of this syndrome were unknown, and there was no defined therapy.
Craig J, McClain +6 more
openaire +2 more sources
Non-alcoholic Steatohepatitis and Cancer
Clinics in Liver Disease, 2007Hepatocellular carcinoma (HCC) is part of the natural history of non-alcoholic steatohepatitis (NASH). A significant proportion of people who have cryptogenic cirrhosis develop HCC. NASH-related cirrhosis carries a substantial risk for early HCC development.
openaire +3 more sources
Non‐alcoholic steatohepatitis in children
Pediatric Transplantation, 2004Abstract: Obesity has emerged as a significant new health problem in the pediatric population. Non‐alcoholic steatohepatitis (NASH) is an entity in the spectrum of non‐alcoholic fatty liver disease (NAFLD) ranges from fat in the liver – simple steatosis, NASH/ steatohepatitis – fat with inflammation and/or fibrosis to advanced fibrosis and cirrhosis ...
openaire +2 more sources
Non-Alcoholic Steatohepatitis: Clinical Significance and Pathogenesis
Scandinavian Journal of Gastroenterology, 2001Non-alcoholic steatohepatitis (NASH) is a form of liver disease resembling alcoholic liver disease in a patient who does not consume significant amounts of alcohol. Since its first description in 1980 it has been recognized with increasing frequency. The natural course is relatively benign, but liver cirrhosis.
openaire +3 more sources
Efruxifermin in non-alcoholic steatohepatitis
The Lancet Gastroenterology & Hepatology, 2023Sara, Mahgoub, Philip N, Newsome
openaire +2 more sources
[Non-alcoholic steatohepatitis].
Gastroenterologie clinique et biologique, 2003Nonalcoholic steatohepatitis (NASH) is a condition characterized histologically by macrovesicular steatosis and lobular hepatitis with necrosis or ballooning degeneration and/or fibrosis--a picture resembling alcoholic hepatitis, in the absence of alcohol abuse. Most patients with NASH are asymptomatic, and the disease is detected incidentally.
P, Petit, J P, Zarski
+6 more sources